Financial Performance - For the first nine months of 2025, the company achieved a revenue of RMB 2.511 billion, representing a year-on-year growth of 35.8%[13] - The gross profit margin increased to 38.36%, up by 4.92% compared to the same period in 2024[13] - The net profit attributable to shareholders reached RMB 658 million, a significant increase of 52.62% year-on-year, indicating improved profitability and operational efficiency[14] - The company's revenue for the third quarter reached ¥830,093,588.80, representing a 29.25% increase compared to the same period last year[52] - Net profit attributable to shareholders was ¥225,632,111.39, a 55.06% increase year-over-year[52] - The company reported a basic earnings per share of ¥1.04, up 55.22% from the previous year[52] - Total operating revenue for the current period reached ¥2,511,429,964, an increase of 35.7% compared to ¥1,849,333,507.64 in the previous period[70] - Net profit for the current period was ¥657,534,469.55, representing a 52.5% increase from ¥430,822,019.02 in the previous period[70] - The total comprehensive income amounted to approximately ¥617.89 million, compared to ¥410.67 million in the previous period, reflecting a growth of 50.5%[72] - Basic and diluted earnings per share increased to ¥3.02 from ¥1.99, marking a 51.3% rise[72] Customer and Market Expansion - Approximately 92.17% of the company's products were exported to the U.S. market, with 84.65% produced in Vietnam, enhancing cost efficiency and risk management[10] - The top ten customers were all from the U.S. market, with retail customers accounting for 70% of total sales, and nine out of ten customers saw procurement growth ranging from 16.64% to 635.28%[17] - The company added 67 new customers in the first nine months of 2025, with 63 from U.S. retail channels, indicating a strong expansion in the U.S. market[17] - Sales to U.S. retail customers accounted for 67.16% of total revenue, highlighting the growing influence and revenue share from this segment[19] - The company has made substantial progress in acquiring high-quality new clients, including a lifestyle brand with over 100 retail stores across 30 states, which has already placed multiple orders[36] - Another new client, a century-old mid-to-high-end furniture retailer with over 100 stores in 17 states, has transitioned from evaluation to execution, marking a significant partnership milestone[40] - The company has established a new collaboration with a large department store group, confirming product categories and styles for upcoming orders, further penetrating the high-end retail channel[39] Operational Efficiency and Strategy - The company is focusing on improving its electric bed business through product development and sales channel enhancements, aiming to regain growth momentum[14] - The strategic layout in Vietnam is expected to strengthen the company's competitive position in the U.S. market and enhance global competitiveness[10] - Clients have expressed strong trust in the company's operational model, stating that the current product structure and supply chain efficiency are effective, even amidst tariff uncertainties[35] - The company's commitment to innovation and quality has been validated by client feedback, reinforcing its strategic direction and operational effectiveness[34] - The company maintains a frugal culture, avoiding extravagant expenditures and opting for shared accommodations during exhibitions, which fosters team cohesion and reflects its core values[42] Financial Position and Cash Flow - Total assets at the end of the reporting period were ¥5,118,818,579.80, reflecting a 17.78% increase from the end of the previous year[52] - The company experienced a significant increase in sales expenses, which rose by 62.50% to ¥81,118,589.54 due to higher compensation and travel costs related to sales[59] - Research and development expenses increased by 38.88% to ¥126,319,072.08, driven by investments in new product development[59] - The net cash flow from operating activities increased by 28.72% to ¥556,602,258.03, primarily due to increased sales revenue and improved collections[60] - The net cash flow from investing activities decreased significantly by 365.34% to -¥802,999,111.96, mainly attributed to increased purchases of financial products[60] - The net cash flow from financing activities improved by 22.79% to -¥81,826,088.02, primarily due to an increase in short-term borrowings[60] - The cash and cash equivalents at the end of the period were approximately ¥1.74 billion, down from ¥2.09 billion at the beginning of the period[75] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,450, with no preferred shareholders[62] - The largest shareholder, Li Xiaoqin, holds 43.10% of the shares, amounting to 93,774,720 shares[62] - The second-largest shareholder, Ningbo Meishan Free Trade Port Area Suiyuxinrui Investment Co., Ltd., holds 24.01% of the shares, totaling 52,241,280 shares[62] - The company has a total of 125,055,937 restricted shares at the beginning of the period, with 68,875,950 shares released during the period[64] - The company plans to release restricted shares for Li Xiaoqin and others in March 2025[64] - The company has not reported any significant changes in the top 10 shareholders participating in margin trading[63] - There are no preferred shareholders or changes in restricted shares reported for the period[64]

江苏常熟农村商业银行股份有限公司 2025 年第三季度报告 证券代码：601128 证券简称：常熟银行 江苏常熟农村商业银行股份有限公司 2025 年第三季度报告 江苏常熟农村商业银行股份有限公司（以下简称"本行"）董事会及全体董事保证本公告内 容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担 个别及连带责任。 重要内容提示 1.公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、 误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 2.公司负责人薛文、行长包剑、主管会计工作负责人程鹏飞及会计机构负责人（会计主管人员） 范丽斌保证季度报告中财务信息的真实、准确、完整。 3.第三季度财务报表未经审计 1 / 11 江苏常熟农村商业银行股份有限公司 2025 年第三季度报告 一、主要财务数据 （三）主要会计数据、财务指标发生变动的情况、原因 | 项目名称 | 变动比例（%） | 主要原因 | | --- | --- | --- | | 衍生金融资产 | (56.38) | 衍生金融工具估值变动 | | 买入返售金融资产 | 100.00 | 买入 ...

证券代码：002357 证券简称：富临运业 公告编号：2025-037 四川富临运业集团股份有限公司 2025 年第三季度报告 四川富临运业集团股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 209,728,673.10 | -3.62% | 614,747,806.52 | -4.90% | | 归属于上市公司股东 | 40,530,450.48 | 389.99% | 155,639,831.77 | 73.16% | | 的净利润（元） | ...

证券代码：002224 证券简称：三 力 士 公告编号：2025-041 三力士股份有限公司 2025 年第三季度报告 三力士股份有限公司 2025 年第三季度报告 【2025 年 10 月】 1 三力士股份有限公司 2025 年第三季度报告 三力士股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 □是 否 2 三力士股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 273,556,525.57 | 0.14% | 714,303,749.77 | 21.75 ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥515,591,024.16, representing a decrease of 1.56% compared to the same period last year[3]. - The total profit for the period was -¥9,542,228.04, with a year-to-date profit of ¥30,680,187.85, reflecting a significant decline of 84.80% year-on-year[3]. - The net profit attributable to shareholders was -¥8,911,745.94 for the quarter, and ¥31,365,392.29 year-to-date, marking a decrease of 76.22% compared to the previous year[3]. - The basic and diluted earnings per share for the quarter were both -¥0.0135, down 76.20% year-to-date from ¥0.0475[3]. - Total operating revenue for the first three quarters of 2025 was CNY 1,621,792,421.02, a decrease of 16.0% compared to CNY 1,931,230,180.59 in the same period of 2024[17]. - Net profit for the first three quarters of 2025 was CNY 30,634,986.38, a decline of 76.7% compared to CNY 131,135,822.40 in 2024[18]. - Basic earnings per share for the first three quarters of 2025 is CNY 0.0475, down from CNY 0.1996 in the same period of 2024[19]. Assets and Liabilities - Total assets at the end of the reporting period were ¥4,215,710,097.20, a decrease of 1.42% from the end of the previous year[5]. - The company's total assets amounted to CNY 4,215,710,097.20, slightly down from CNY 4,276,276,026.30 in the previous period[16]. - Total liabilities decreased to CNY 1,040,369,956.94 from CNY 1,083,040,189.25, reflecting a reduction of 3.9%[15]. - The equity attributable to shareholders decreased by 0.47% to ¥3,165,025,873.87 compared to the end of the previous year[5]. - The company's equity attributable to shareholders was CNY 3,165,025,873.87, down from CNY 3,179,910,026.46, indicating a decrease of 0.5%[16]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥27,009,234.39, an increase of 57.18% compared to the previous year[3]. - The company's cash flow from operating activities showed a significant decline, impacting overall liquidity[18]. - Operating cash inflow for the first three quarters of 2025 is CNY 1,608,168,297.73, a decrease of 15.06% compared to CNY 1,893,750,956.10 in 2024[20]. - Net cash flow from operating activities increased to CNY 27,009,234.39 in 2025, compared to CNY 17,183,456.09 in 2024, representing a growth of 57.96%[20]. - Cash outflow from investment activities in 2025 was CNY 4,709,887.35, down from CNY 7,415,129.23 in 2024, indicating a reduction of 36.36%[21]. - The ending cash and cash equivalents balance for 2025 is CNY 1,154,522,562.16, compared to CNY 1,095,326,306.06 in 2024, showing an increase of 5.39%[21]. Expenses and Investments - Research and development expenses rose by 30.51% as the company increased its investment in R&D[9]. - Research and development expenses increased to CNY 4,262,913.29, up from CNY 3,266,417.89, representing a growth of 30.5%[17]. - The net cash flow from investing activities was -194 million, mainly due to the previous period's receipt of fund project dividends[9]. - The company reported a financial income of CNY 6,262,793.17, compared to CNY 9,707,197.93 in the previous year, a decrease of 35.3%[17]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,454[11]. - The largest shareholder, Qingdao Publishing Group Co., Ltd., holds 374,191,691 shares, accounting for 56.63% of total shares[11]. Other Notable Points - Non-recurring gains and losses for the period totaled ¥33,538,124.05, with significant contributions from government subsidies and financial asset valuation changes[8]. - The decline in profits was primarily attributed to changes in market sales structure and a significant decrease in sales of educational materials[8]. - Accounts receivable decreased by 55.19% due to a reduction in commercial notes received during the reporting period[9]. - Prepayments increased by 61.72% primarily due to prepayment of copyright fees and book procurement[9]. - Deferred income increased by 40.24% due to government fund project payments received during the reporting period[9]. - The company experienced a 99.94% decrease in income tax expenses due to changes in tax incentive policies[9]. - The company reported a significant asset disposal gain of 12,449.09 million due to compensation from demolition[9]. - The company did not report any net profit from the merged entity in the current or previous periods[19]. - The company is not applying new accounting standards for the year 2025[22].

Financial Performance - The company's operating revenue for the third quarter reached ¥62,164,622.58, representing an increase of 83.88% compared to the same period last year[4] - The total profit for the period was -¥57,553,671.40, with a year-to-date total profit of -¥122,617,464.03[4] - The net profit attributable to shareholders was -¥56,507,418.21 for the quarter, and -¥114,055,608.72 year-to-date[4] - Total operating revenue for the first three quarters of 2025 reached ¥187,477,071.80, a significant increase from ¥92,120,994.70 in the same period of 2024, representing a growth of approximately 103.5%[22] - The net loss for the first three quarters of 2025 was ¥125,067,718.83, worsening from a net loss of ¥76,172,852.88 in the same period of 2024[22] - The company reported a basic and diluted earnings per share of -¥0.25 for the first three quarters of 2025, compared to -¥0.17 in the same period of 2024[23] Research and Development - Research and development expenses totaled ¥26,604,937.33, a decrease of 16.04% year-on-year, accounting for 42.80% of operating revenue[5] - The proportion of R&D investment to operating revenue decreased by 50.93 percentage points in the current period compared to the previous year[9] - Research and development expenses for the first three quarters of 2025 were ¥82,004,871.18, compared to ¥70,657,967.30 in the same period of 2024, marking an increase of approximately 16.0%[22] Assets and Liabilities - Total assets increased by 5.04% to ¥1,776,952,165.28 compared to the end of the previous year[5] - The company's total assets as of September 30, 2025, are ¥1,776,952,165.28, compared to ¥1,691,716,774.29 at the end of 2024[17] - The company's total liabilities increased to ¥484,878,381.87 in 2025 from ¥411,577,279.87 in 2024, reflecting a rise of approximately 17.7%[22] - The total equity attributable to shareholders decreased to ¥1,249,104,213.69 in 2025 from ¥1,267,845,501.07 in 2024, a decline of about 1.4%[22] - The total non-current liabilities rose to ¥328,385,286.70 in 2025 from ¥254,973,637.94 in 2024, indicating an increase of about 28.8%[22] Cash Flow - The company reported a net cash flow from operating activities of -¥29,946,024.19 year-to-date[4] - The net cash flow from operating activities was -$29,946,024.19, compared to -$116,724,720.20 in the previous period, indicating an improvement[26] - Total cash inflow from operating activities amounted to $272,023,070.98, while cash outflow was $301,969,095.17, resulting in a net cash flow deficit[26] - Cash inflow from investment activities was $74,376,114.28, down from $256,669,258.91 in the previous period, leading to a net cash flow of -$122,878,797.53[26] - The cash inflow from financing activities totaled $162,224,864.20, with a net cash flow of $130,036,151.31, a significant increase compared to the previous period[27] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,347[12] - The largest shareholder, Zhang Songgen, holds 75,918,700 shares, representing 16.77% of the total shares[12] Operational Highlights - The company experienced a significant increase in sales and technical service revenue due to a recovering market environment[9] - The company has conducted over 12,000 surgeries using the Tianji orthopedic surgical robot in Q3 2025, with a cumulative total of over 130,000 surgeries performed[15]

深圳市迪威迅股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 深圳市迪威迅股份有限公司 2025 年第三季度报告 证券代码：300167 证券简称：ST 迪威迅 公告编号：2025-072 深圳市迪威迅股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入（元） | 127,332,029.76 | 19.75% | 384,400,018.29 | 17.43% | | 归属于上市公司股东 | -3,870,792.94 | -14.63% | -7,045,745.41 | 75.61% | | 的净利润（元） | | | | | | 归属于上市公司股东 的扣除非经常性损益 | -4,230,345.37 | -9 ...

Financial Performance - The company's revenue for Q3 2025 was ¥357,723,444.32, representing a decrease of 8.17% compared to the same period last year[3] - The total profit for the period was ¥80,847,202.96, down 35.46% year-on-year[3] - Net profit attributable to shareholders was ¥76,848,645.53, a decline of 29.85% compared to the previous year[3] - Basic earnings per share for the period were ¥0.40, reflecting a decrease of 31.03% year-on-year[3] - Total operating revenue for the first three quarters of 2025 reached ¥1,144,414,504.11, an increase of 6.4% compared to ¥1,075,267,105.77 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was ¥278,623,253.61, a decrease of 8.4% from ¥304,046,515.08 in the previous year[19] - Earnings per share (EPS) for the first three quarters of 2025 was ¥1.51, down from ¥1.68 in the same period of 2024[20] Assets and Liabilities - Total assets at the end of the period were ¥3,902,983,843.01, an increase of 11.61% from the end of the previous year[5] - Total assets increased to ¥3,902,983,843.01 from ¥3,496,968,135.88, representing a growth of 11.6%[16] - Total liabilities rose to ¥894,960,084.85, compared to ¥862,711,621.16, indicating an increase of 3.4%[16] - The company's goodwill increased to ¥190,861,311.37 from ¥139,107,544.38, marking a rise of 37.0%[15] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥230,096,531.01, an increase of 6.01%[3] - Cash inflow from operating activities for the first three quarters of 2025 reached approximately $1.15 billion, an increase of 11.5% compared to $1.03 billion in the same period of 2024[25] - Net cash flow from operating activities amounted to $230.1 million, up from $217.1 million year-over-year, reflecting a growth of 6.9%[25] - Cash inflow from investment activities significantly increased to $1.00 billion, compared to $215.3 million in the first three quarters of 2024, marking a substantial rise of 365.5%[25] - The net cash flow from investment activities turned positive at $38.3 million, a recovery from a negative $597.1 million in the previous year[25] - Total cash and cash equivalents at the end of the period stood at $680.1 million, a significant increase from $266.2 million at the end of Q3 2024[26] - Cash inflow from financing activities decreased to $322.0 million from $492.0 million in the same period last year, reflecting a decline of 34.6%[25] - The net cash flow from financing activities was $49.1 million, down from $114.5 million in the previous year, indicating a decrease of 57.1%[25] - The company reported a net increase in cash and cash equivalents of $316.2 million, contrasting with a decrease of $265.6 million in the same period last year[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 17,214[11] - The largest shareholder, Jie Jiangbing, holds 24,490,410 shares, representing 12.66% of total shares[11] - The company has a total of 10 major shareholders, with the top two holding a combined 18.31% of shares[12] - The company reported no significant changes in the participation of major shareholders in margin trading and securities lending[12] Research and Development - Research and development expenses totaled ¥36,985,646.67, accounting for 10.34% of revenue, an increase of 0.09 percentage points[5] - Research and development expenses for the first three quarters were ¥70,221,069.34, a decrease of 9.2% from ¥77,654,725.68 in the previous year[19] Operational Insights - The decline in total profit was primarily due to decreased revenue from artificial lenses and contact lenses, influenced by national procurement policies and market competition[9] - The company has not disclosed any new product developments or market expansion strategies in the current reporting period[13] - There are no significant reminders or additional important information regarding the company's operational situation during the reporting period[13] - The company adjusted its financial statements due to a change in accounting standards, resulting in an increase in operating costs by ¥6,489,041.81[21] Other Financial Metrics - Total operating costs amounted to ¥830,567,968.09, up from ¥720,300,574.45, reflecting a year-over-year increase of 15.3%[18] - The return on equity was 2.74%, a decrease of 3.12 percentage points compared to the previous year[5] - The company reported non-recurring gains of ¥1,524,008.91 for the period[7] - Non-current assets decreased from ¥1,834,000,000 to ¥1,800,000,000, a decline of 1.84%[14] - Total current assets increased to ¥1,587,115,954.59 from ¥1,180,629,881.84, reflecting a growth of 34.38%[14] - Accounts receivable rose to ¥498,459,333.41 from ¥353,147,013.28, an increase of 41.16%[14] - The company received $991.2 million from investment recoveries, a significant increase from $214.9 million in the previous year, representing a growth of 361.5%[25]

袁隆平农业高科技股份有限公司 2025 年第三季度报告 证券代码：000998 证券简称：隆平高科 公告编号：2025-67 袁隆平农业高科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）声明：保证季度报告中财务信息的真实、准 确、完整。 1 袁隆平农业高科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入（元） | 674,909,236.09 | 125.71% | 2,840,882,256. ...

Revenue and Profit - The company's revenue for Q3 2025 reached ¥300,350,261.64, representing a year-over-year increase of 64.68%[4] - Total profit for the period was ¥130,607,340.82, a decrease of 20.88% compared to the same period last year[4] - Net profit attributable to shareholders was ¥114,408,672.85, down 23.63% year-over-year[4] - Total operating revenue for the first three quarters of 2025 reached ¥1,014,780,041.62, an increase from ¥969,564,236.70 in the same period of 2024, representing a growth of approximately 4.3%[19] - Operating profit for the first three quarters of 2025 was ¥497,462,954.23, compared to ¥637,790,237.07 in 2024, reflecting a decrease of approximately 22.0%[20] - Net profit for the first three quarters of 2025 was ¥423,065,173.14, down from ¥547,177,167.51 in 2024, a decline of about 22.7%[20] - Basic earnings per share for the first three quarters of 2025 were ¥3.54, compared to ¥4.49 in the same period of 2024, a decrease of approximately 21.2%[21] Expenses and Costs - Research and development expenses totaled ¥25,851,086.52, a decrease of 28.12% compared to the same period last year[5] - Total operating costs for the first three quarters of 2025 were ¥563,934,629.28, up from ¥443,293,120.87 in 2024, indicating an increase of about 27.3%[20] - The company paid CNY 43,558,034.80 in dividends and interest in the first three quarters of 2025, a decrease from CNY 248,178,759.00 in the same period of 2024, reflecting a reduction of about 82.5%[25] Assets and Liabilities - The total assets of the company increased by 10.27% year-over-year, reaching ¥4,732,362,656.89[5] - Total assets increased to ¥4,732,362,656.89 in 2025 from ¥4,291,597,451.31 in 2024, marking a growth of about 10.3%[16] - Total liabilities rose to ¥750,072,716.20 in 2025, compared to ¥469,125,424.12 in 2024, an increase of approximately 59.9%[16] - Non-current liabilities totaled ¥135,054,880.90 in 2025, slightly up from ¥130,086,642.62 in 2024, indicating a growth of about 3.7%[16] - The company's total equity increased to ¥3,982,289,940.69 in 2025 from ¥3,822,472,027.19 in 2024, reflecting a growth of approximately 4.2%[16] Cash Flow - The company reported a cash flow from operating activities of ¥363,201,648.36, a decrease of 3.26% year-over-year[4] - In the first three quarters of 2025, the net cash flow from operating activities was CNY 363,201,648.36, compared to CNY 375,446,862.07 in the same period of 2024, reflecting a decrease of approximately 2.9%[24] - Total cash inflow from investment activities in the first three quarters of 2025 was CNY 2,934,168,253.08, while cash outflow was CNY 4,305,020,875.92, resulting in a net cash flow of -CNY 1,370,852,622.84[25] - The total cash outflow for operating activities in the first three quarters of 2025 was CNY 598,595,046.84, compared to CNY 651,367,599.52 in 2024, indicating a decrease of about 8.1%[24] - The company's cash inflow from financing activities was CNY 126,000,000.00 in the first three quarters of 2025, compared to CNY 35,000,000.00 in the same period of 2024, marking an increase of approximately 260%[25] Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,990[11] - MicroPort Endovascular holds 39.77% of shares, totaling 49,025,370 shares[11] - The company has repurchased a total of 1,263,043 shares, accounting for 1.02% of total share capital, with a total expenditure of RMB 132,745,761.84[13] - The second phase of the share repurchase plan has been completed as of the report date[13] - The company has not disclosed any significant changes in shareholder relationships or actions among the top shareholders[12] Operational Insights - The company aims to optimize its R&D team structure and improve the output ratio of R&D investments, leading to a reduction in R&D spending[9] - The company continues to expand its overseas market presence, enhancing product competitiveness and steadily increasing production and sales volumes[9] - The company has not identified any other significant operational issues during the reporting period[13] - The cash flow from operating activities showed a slight increase in 2025 compared to 2024, indicating stable operational performance despite challenges in sales revenue[24] - The company is not applying new accounting standards or interpretations for the first time in 2025, maintaining consistency in financial reporting[26]